Clinical Trial

A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles in the Cheek Area

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to evaluate the safety of GP0122 and GP0124 for the correction of lines and wrinkles in the cheek area.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-14
notable Trial sites expanded: 0 -> 5 locations 2026-08-14
notable Primary completion pushed: 2027-04-30 -> 2027-05-30 2026-08-14
Trial Details
NCT Number NCT07344584
Lead Sponsor Galderma R&D
Conditions Wrinkle Reduction
Enrollment 60 participants
Start Date 2026-02-17
Primary Completion 2027-05-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-13